Mr. Samidin was diagnosed with a rare leiomyoma tumor in the pelvic cavity (lower abdomen) in 2012. The tumor mass was attached to the outer wall of the bladder and major blood vessels, making it inoperable. To release the adhesions of the mass to the aorta (large blood vessel) and surrounding tissues, Mr. Samidin underwent ECCT treatment for approximately 6 months, followed by surgery, which was successful and clean. Mr. Samidin continued to use ECCT after the surgery to prevent recurrence. For 5 years, there was no recurrence. However, coinciding with Mr. Samidin’s remission after 5 years, his wife, Mrs. Sudartati, who had been accompanying him throughout his treatment, was also diagnosed with a brain tumor, located just behind her left eye, attached to the brainstem and cerebellum, making it inoperable. Mrs. Sudartati then also started using ECCT. Despite using ECCT, her brain tumor remained inoperable because it was gripping the optic nerve and other vital nerves. Mrs. Sudartati could only rely on ECCT, which has a slow effect on benign tumors. After 5 years of using ECCT, the tumor mass slightly shrank, and its density began to fade, but it did not disappear. By the end of 2024, both Mrs. Sudartati and Mr. Samidin each celebrated 5 and 10 years as survivors.
RIGHT: CT scan images of Mr. Samidin before and after using ECCT followed by surgery. MIDDLE: MRI images of Mrs. Sudartati before and after 5 years of using ECCT, showing a reduction and fading of the tumor mass. LEFT: A photo of Mr. Samidin and Mrs. Sudartati after 5 and 10 years as survivors.
In 2012, Mr. Samidin was diagnosed with a leiomyoma tumor in his abdominal cavity. The tumor was attached to the outer wall of the bladder and the aorta (large blood vessel), measuring up to 23 cm, making direct surgery impossible. If surgery had been performed, the entire bladder would have had to be removed, and the portion attached to the aorta could not be removed, posing a high risk of recurrence. To help release the adhesions, Mr. Samidin used an ECCT device for 6 months. After using the device, the tumor could be removed cleanly without affecting other organs. He continued to use ECCT after surgery to prevent recurrence.
In 2019, after 5 years of using ECCT, Mr. Samidin had not experienced any recurrence. However, in the same year, Mrs. Sudartati was diagnosed with a brain tumor. The tumor was located behind her left eye, filling the cavity between the eye and the brainstem, pressing on the brainstem and cerebellum, and spreading to the larger brain, making it inoperable.
ECCT can kill benign tumors, but since tumors are generally encased in a membrane, dead cells cannot be effectively eliminated, so without surgery, the device can only cause the tumor to stagnate or remain unchanged.
For 5 years, Mrs. Sudartati’s brain tumor shrank by only a few millimeters but did not disappear. However, she was able to accept this condition, even after 5 years. This is something many people in similar situations may find difficult to accept. Many cannot accept stagnation, but stagnation may be sufficient, as the risk of attempting to remove the tumor surgically is death.
Today, Mr. Samidin and Mrs. Sudartati have each surpassed 10 and 5 years in good health. May they continue to stay healthy, live long lives, and remain happy.
